InvestorsHub Logo
Post# of 176728
Next 10
Followers 0
Posts 415
Boards Moderated 0
Alias Born 11/23/2011

Re: None

Thursday, 03/02/2023 8:26:59 AM

Thursday, March 02, 2023 8:26:59 AM

Post# of 176728
Honestly, what type of actual dilution would it take for the next round? If the stock is trading in the range of $0.30 - $0.60 after Vivos gets the go ahead for clinical testing and they want to raise 10 million dollars, what would that look like? 40 million shares at $0.25 per share would get you to the target. That would be a little over 10% dilution. I would accept that and think it would be a good trade off. Do you think that is in the ball park or would they not be able to get that high of a per share price for an offering?

----------------------------------------------------------------------------------------------------------
Page F-9

Research and development of the Company’s brachytherapy product line has been funded with proceeds from the sale of equity and debt securities. The Company may require additional funding of approximately $2.5 million annually to maintain current operating activities. Over the next 12 to 48 months, the Company believes it will cost approximately $9 million to: (1) fund the FDA approval process to conduct human clinical trials, (2) conduct Phase I, pilot, clinical trials, (3) activate several regional clinics to administer IsoPet® across the county, (4) create an independent production center within the current production site to create a template for future international manufacturing, and (5) initiate regulatory approval processes outside of the United States. The proceeds to be raised from the recent qualified Regulation A+ will be used to continue to fund this development.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News